JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Robust tris-cyclometalated iridium(III) phosphors with ligands for effective charge carrier injection/transport: synthesis, redox, photophysical, and electrophosphorescent behavior.

With the target to design and develop new functionalized green triplet light emitters that possess distinctive electronic properties for robust and highly efficient phosphorescent organic light-emitting diodes (PHOLEDs), a series of bluish-green to yellow-green phosphorescent tris-cyclometalated homoleptic iridium(III) complexes [Ir(ppy-X)(3)] (X=SiPh(3), GePh(3), NPh(2), POPh(2), OPh, SPh, SO(2)Ph, Hppy=2-phenylpyridine) have been synthesized and fully characterized by spectroscopic, redox, and photophysical methods. By chemically manipulating the lowest triplet-state character of Ir(ppy)(3) with some functional main-group 14-16 moieties on the phenyl ring of ppy, a new family of metallophosphors with high-emission quantum yields, short triplet-state lifetimes, and good hole-injection/hole-transporting or electron-injection/electron-transporting properties can be obtained. Remarkably, all of these Ir(III) complexes show outstanding electrophosphorescent performance in multilayer doped devices that surpass that of the state-of-the-art green-emitting dopant Ir(ppy)(3). The devices described herein can reach the maximum external quantum efficiency (eta(ext)) of 12.3 %, luminance efficiency (eta(L)) of 50.8 cd A(-1), power efficiency (eta(p)) of 36.9 Lm W(-1) for [Ir(ppy-SiPh(3))(3)], 13.9 %, 60.8 cd A(-1), 49.1 Lm W(-1) for [Ir(ppy-NPh(2))(3)], and 10.1 %, 37.6 cd A(-1), 26.1 Lm W(-1) for [Ir(ppy-SO(2)Ph)(3)]. These results provide a completely new and effective strategy for carrier injection into the electrophosphor to afford high-performance PHOLEDs suitable for various display applications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app